Catalyst Wire Dossier Catalyst Wire Dossier

MRX-6

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MRX-6, covering 2015-04-21 to 2015-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis [Phase 1, Phase 2]

See pricing